Catalyst Wire Dossier Catalyst Wire Dossier

Acolbifene

acolbifene
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Acolbifene, covering 2013-12-11 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer [Phase 2]

See pricing